期刊文献+

Wnt3a对骨髓间充质干细胞成软骨分化的影响 被引量:2

Effect of Wnt3a on chondrogenic differentiation of mesenchymal stem cells
原文传递
导出
摘要 [目的]探讨Wnt3a基因对骨髓间充质干细胞(BMSCs)成软骨分化的影响。[方法]分离培养大鼠骨髓间充质干细胞(BMSCs),携带Wnt3a及阴性对照基因(Mock)的慢病毒感染骨髓间充质干细胞,构建过表达Wnt3a骨髓间充质干细胞;采用甲苯胺蓝染色及QPCR观察Wnt3a对骨髓间充质干细胞成软骨分化能力的影响;使用MTT法观察Wnt3a对骨髓间充质干细胞增殖能力的影响。[结果]在0~72 h内,实验组MTT法检测吸光值明显大于对照组(P〈0.05);BMSCs体外成软骨诱导后,实验组细胞团明显小于对照组,且甲苯胺蓝染色较浅;实验组与对照组比较,成软骨指标Col2A1、Aggrecan和SOX9的m RNA表达降低(P〈0.05)。[结论]Wnt3a可促进骨髓间充质干细胞增殖,但抑制了骨髓间充质干细胞的成软骨分化。 [Objective]To evaluate effect of Wnt3 a gene transfection by lentivirus carrier on chondrogenic differentiation of bone marrow mesenchymal stem cells( BMSCs). [Method]BMSCs from the rat were isolated and cultured,subsequently infected by lentivirus vector inserted Wnt3a- expressing coding sequence to establish an over- expression of Wnt3 a model,while the Mock- expressing coding sequence was used as control. Toluidine blue staining and quantitative polymerase chain reaction( QPCR) were utilized to evaluate effect of Wnt3 a on chondrogenic differentiation,additionally MMT assay was used to observe cell proliferation and cell survival. [Result]The MTT showed that Wnt3 a enhanced proliferation of BMSCs. Compared with BMSCs infected with the control lentivirus,elevated expression of Wnt3 a in BMSCs decreased the accumulation of matrix proteoglycans,which was shown by toluidine blue staining,and decreased expression of chondrogenesis related factors,such as level of m RNAs of COL2A1,aggrecan,and SOX9. [Conclusion]Over- expression of Wnt3 a increases MSC proliferation,however,inhibits chondrogenesis of BMSCs.
出处 《中国矫形外科杂志》 CAS CSCD 北大核心 2016年第2期155-159,共5页 Orthopedic Journal of China
基金 国家自然科学基金资助项目(编号:81271983)
关键词 WNT3A 骨髓间充质干细胞 成软骨分化 Wnt3a BMSCs chondrogenic differentiation
  • 相关文献

参考文献2

二级参考文献35

  • 1Ossendorf C, Kaps C, Kreuz P,et al. Treatment of posttraumatic and focal osteoarthritic cartilage defects of the knee with autologous poly- mer-based three-dimensional chondrocyte grafts:2-year clinical results [ J]. Arthritis Res Ther,2007 ,9 :41.
  • 2Crawford D, Potter H, Foo LF. Autogenous chondrocyte collagen ma-trix bioengineered "cartilage" patch Neocart for the treatment of chon- dral defects in human knees. A prospective safety trial at two years [ R]. Warsaw Poland:ICRS meeting,2007.
  • 3Verdonk PCM. Allogenic chondrocyte-based cartilage repair using alg- inate beads[M]. Totowa,New Jersey:Humana Press,2007.
  • 4Kessler MW,Ackerman G,Dines JS,et al. Emerging technologies and fourth generation issues in cartilage repair[ J ]. Sports Med Arthrosc, 2008,4:246 - 254.
  • 5Knutsen G,Drogset JO,Engebretsen L,et al. A randomized trial com- paring autologous chondrocyte implantation with microfracture. Find- ings at five years [ J ]. J Bone Joint Surg Am,2007,10:2105 - 2112.
  • 6Horas U,Pelinkovic D, Herr G,et al. Autologous chondroeyte implan-tation and osteochondral cylinder transplantation in cartilage repair of the knee joint. A prospective,comparative trial[ J]. J Bone Joint Surg Am ,2003,2 : 185 - 192.
  • 7Bentley G, Biant LC, Carrington RW, et al. A prospective, randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee[ J]. J Bone Joint Surg Br,2003, 2:223 - 230.
  • 8Bartlett W, Skinner JA, Gooding CR,et al. Autologous chondrocyte im- plantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee:a prospective, randomised study [ J ]. J Bone Joint Surg Br,2005,5:640 - 645.
  • 9Curl WW, Krome J, Gordon ES, et al. Cartilage injuries : a review of 31,516 knee arthroscopies[ J]. Arthroscopy, 1997,13:456 -460.
  • 10Kerker JT, Leo A J, Sgaglione NA. Cartilage repair: synthetics and scaffolds: basic science, surgical techniques, and clinical outcomes [ J]. Sports Med Arthrosc ,2008,4:208 - 216.

共引文献17

同被引文献20

  • 1Liang Y,Fu Y,Qi R,et al.Cartilage oligomeric matrix protein is a natural inhibitor of thrombin.Blood,2015,126(7):905-914.
  • 2Kluzek S,Bay-Jensen A C,Spector T,et al.Higher serum levels of cartilage oligomeric matrix protein(comp)are associated with self-reported knee pain.Osteoarthr Cartilage,2014,22(3):S74.
  • 3Kluzek S,Bay-Jensen A C,Judge A,et al.Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis.A community-based cohort of middleaged women.Biomarkers,2015,20(8):557-564.
  • 4Kim M J,Lee B,Yang K,et al.BMP-2 peptide-functionalized nanopatterned substrates for enhanced osteogenic differentiation of human mesenchymal stem cells.Biomaterials,2013,34(30):7236-7246.
  • 5Barati D,Shariati S R,Moeinzadeh S,et al.Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel.J Controll Release,2016,223:126-136.
  • 6Guzzo R M,Gibson J,Xu R H,et al.Efficient differentiation of human i PSC‐derived mesenchymal stem cells to chondroprogenitor cells.J Cell Biochem,2013,114(2):480-490.
  • 7Dharmavaram R M,Liu G,Tuan R S,et al.Stable transfection of human fetal chondrocytes with a type II procollagen minigene:expression of the mutant protein and alterations in the structure of the extracellular matrix in vitro.Arthritis Rheum,1999,42(7):1433-1442.
  • 8Du Y,Wang Y,Wang L,et al.Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2.Circ Res,2011,108(8):917-928.
  • 9Ishida K,Acharya C,Christiansen B A,et al.Cartilage oligomeric matrix protein enhances osteogenesis by directly binding and activating bone morphogenetic protein-2.Bone,2013,55(1):23-35.
  • 10Guo P,Shi Z L,Liu A,et al.Effects of cartilage oligomeric matrix protein on bone morphogenetic protein-2-induced differentiation of mesenchymal stem cells.Orthop Surg,2014,6(4):280-287.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部